Related Experiment Video
Updated: Jul 12, 2026
23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
[Multidrug-resistant tuberculosis in the pediatric age group].
A Méndez Echevarría1, F Baquero Artigao, M J García Miguel
1Unidad de Infectología Pediátrica, Hospital La Paz, Madrid, España. amendezes@yahoo.es
Anales De Pediatria (Barcelona, Spain : 2003)
|September 6, 2007
Summary
Multidrug-resistant tuberculosis (MDR-TB) in children requires prolonged treatment with second-line drugs, often with toxic effects. Suspect MDR-TB in non-responders, especially immigrants, and use source case sensitivity data for diagnosis.
Area of Science:
- Pediatric infectious diseases
- Microbiology
- Epidemiology
Context:
- Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health challenge, particularly in pediatric populations.
- Diagnosis and management of MDR-TB in children present unique challenges due to limited data and drug availability.
Purpose:
- To elucidate the clinical and epidemiological characteristics of pediatric MDR-TB cases.
- To analyze treatment outcomes and adverse effects in children with MDR-TB.
Summary:
- This retrospective study analyzed eight pediatric patients diagnosed with MDR-TB between 1994 and 2005 in Madrid.
- Pulmonary TB and arthritis were observed, with 50% of patients being immigrants. Drug resistance patterns varied, with some strains resistant to multiple drugs.
- Treatment involved 3-5 second-line drugs for an average of 15 months, resulting in satisfactory outcomes despite some adverse effects.
Impact:
- Highlights the importance of suspecting MDR-TB in children with treatment-resistant or prolonged TB symptoms, especially those from high-resistance regions.
- Emphasizes the need for individualized, prolonged treatment regimens using second-line anti-TB drugs.
- Underscores the potential for adverse effects with extended MDR-TB therapy in children, necessitating careful monitoring.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...